1-1041648-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198576.4(AGRN):​c.1123G>T​(p.Ala375Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00657 in 1,611,148 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A375T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0052 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0067 ( 36 hom. )

Consequence

AGRN
NM_198576.4 missense

Scores

4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.49

Publications

13 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0054303408).
BP6
Variant 1-1041648-G-T is Benign according to our data. Variant chr1-1041648-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 263158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00518 (788/152180) while in subpopulation NFE AF = 0.00694 (472/67966). AF 95% confidence interval is 0.00643. There are 2 homozygotes in GnomAd4. There are 341 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.1123G>T p.Ala375Ser missense_variant Exon 6 of 36 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.1123G>T p.Ala375Ser missense_variant Exon 6 of 36 1 NM_198576.4 ENSP00000368678.2 O00468-6
AGRNENST00000651234.1 linkc.808G>T p.Ala270Ser missense_variant Exon 5 of 38 ENSP00000499046.1 A0A494C1I6
AGRNENST00000652369.2 linkc.808G>T p.Ala270Ser missense_variant Exon 5 of 35 ENSP00000498543.1 A0A494C0G5
AGRNENST00000620552.4 linkc.709G>T p.Ala237Ser missense_variant Exon 6 of 39 5 ENSP00000484607.1 A0A087X208

Frequencies

GnomAD3 genomes
AF:
0.00518
AC:
787
AN:
152064
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00147
Gnomad AMI
AF:
0.0802
Gnomad AMR
AF:
0.00622
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00694
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00493
AC:
1175
AN:
238246
AF XY:
0.00520
show subpopulations
Gnomad AFR exome
AF:
0.00113
Gnomad AMR exome
AF:
0.00388
Gnomad ASJ exome
AF:
0.0121
Gnomad EAS exome
AF:
0.0000564
Gnomad FIN exome
AF:
0.00330
Gnomad NFE exome
AF:
0.00699
Gnomad OTH exome
AF:
0.00561
GnomAD4 exome
AF:
0.00671
AC:
9794
AN:
1458968
Hom.:
36
Cov.:
33
AF XY:
0.00666
AC XY:
4836
AN XY:
725714
show subpopulations
African (AFR)
AF:
0.00147
AC:
49
AN:
33434
American (AMR)
AF:
0.00412
AC:
184
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.0129
AC:
336
AN:
26064
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39656
South Asian (SAS)
AF:
0.00254
AC:
219
AN:
86176
European-Finnish (FIN)
AF:
0.00313
AC:
162
AN:
51828
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5742
European-Non Finnish (NFE)
AF:
0.00752
AC:
8356
AN:
1111144
Other (OTH)
AF:
0.00707
AC:
426
AN:
60276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
691
1381
2072
2762
3453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00518
AC:
788
AN:
152180
Hom.:
2
Cov.:
31
AF XY:
0.00458
AC XY:
341
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41544
American (AMR)
AF:
0.00621
AC:
95
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4822
European-Finnish (FIN)
AF:
0.00226
AC:
24
AN:
10600
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00694
AC:
472
AN:
67966
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
47
93
140
186
233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00647
Hom.:
11
Bravo
AF:
0.00574
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000945
AC:
4
ESP6500EA
AF:
0.00706
AC:
59
ExAC
AF:
0.00466
AC:
560
Asia WGS
AF:
0.00116
AC:
4
AN:
3474
EpiCase
AF:
0.00834
EpiControl
AF:
0.00818

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Aug 30, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27378695) -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AGRN: BS2 -

Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 20, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Feb 02, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 14, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 8 Benign:2
Oct 15, 2018
SIB Swiss Institute of Bioinformatics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as Benign, for Myasthenic syndrome, congenital, 8, autosomal recessive. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder. BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
21
DANN
Uncertain
0.99
Eigen
Benign
-0.062
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.22
N
LIST_S2
Uncertain
0.89
D;D
MetaRNN
Benign
0.0054
T;T
MetaSVM
Benign
-0.58
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
1.5
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.1
N;.
REVEL
Benign
0.27
Sift
Uncertain
0.022
D;.
Sift4G
Benign
0.42
T;T
Vest4
0.46
MVP
0.71
MPC
0.94
ClinPred
0.023
T
GERP RS
4.7
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.7
gMVP
0.23
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138031468; hg19: chr1-977028; COSMIC: COSV65070842; COSMIC: COSV65070842; API